South Olds Medi Center Levittown, PA - 19055

South Olds Medi Center is categorized under Internal Medicine Doctors in Levittown, PA and active since 1996.

South Olds Medi Center was established in 1996, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Donna Hicinbothem, Office Manager at the company’s single location by writing to 1 Sugarmaple Lane, Levittown, Pennsylvania PA 19055 or by phoning (215) 945-8400. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: South Olds Medi Center
Contact Person: Donna Hicinbothem, Office Manager
Address: 1 Sugarmaple Lane, Levittown, Pennsylvania 19055
Phone Number: (215) 945-8400
Annual Revenue (USD): $500.000 to $999.999
Founded: 1996
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

South Olds Medi Center was started in 1996 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Donna Hicinbothem, Office Manager for inquiries that concern South Olds Medi Center by calling the company number (215) 945-8400, as your correspondence is most welcome. Additionally, the physical location of the single location of South Olds Medi Center can be found at the coordinates 40.1492,-74.83034 as well as the street address 1 Sugarmaple Lane in Levittown, Pennsylvania 19055.

For its online presence, you may visit South Olds Medi Center’s website at and engage with its social media outlets through on Twitter and on Facebook.